SLC17A2

Summary

SLC17A2 (solute carrier family 17 member 2, HGNC:10930) is a protein-coding gene on chromosome 6p22.2, encoding Sodium-dependent phosphate transport protein 3 (O00624). Acts as a membrane potential-dependent organic anion transporter, the transport requires a low concentration of chloride ions.

Predicted to enable urate transmembrane transporter activity. Predicted to be involved in phosphate-containing compound metabolic process and sodium ion transport. Predicted to be located in plasma membrane. Predicted to be active in apical plasma membrane.

Source: NCBI Gene 10246 — RefSeq curated summary.

At a glance

• Clinical variants (ClinVar): 66 total
• Druggable target: yes
• MANE Select transcript: NM_001286123

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:10930
Approved symbol	SLC17A2
Name	solute carrier family 17 member 2
Location	6p22.2
Locus type	gene with protein product
Status	Approved
Aliases	NPT3
Ensembl gene	ENSG00000112337
Ensembl biotype	protein_coding
OMIM	611049
Entrez	10246

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 12 protein_coding

ENST00000265425, ENST00000360488, ENST00000377850, ENST00000882944, ENST00000882945, ENST00000882946, ENST00000882947, ENST00000882948, ENST00000882949, ENST00000882950, ENST00000882951, ENST00000882952

RefSeq mRNA: 3 — MANE Select: NM_001286123 NM_001286123, NM_001286125, NM_005835

CCDS: CCDS4567, CCDS69060

Canonical transcript exons

ENST00000377850 — 12 exons

Exon	Start	End
ENSE00000700863	25915736	25915868
ENSE00000700940	25916685	25916846
ENSE00000701210	25921006	25921093
ENSE00000701297	25921179	25921412
ENSE00000928888	25916969	25917087
ENSE00000928889	25918487	25918573
ENSE00001084985	25915499	25915646
ENSE00001176069	25923695	25923906
ENSE00001280464	25925769	25925879
ENSE00002208909	25930277	25930691
ENSE00003529539	25912754	25913451
ENSE00003676320	25914580	25914670

Expression profiles

Bgee: expression breadth broad, 22 present calls, max score 94.36.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1224 / max 72.4414, expressed in 11 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter ID	TPM avg	Samples expressed
72288	0.1627	10
72286	0.0644	8
72287	0.0580	9

Top tissues by expression

280 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
right lobe of liver	UBERON:0001114	94.36	gold quality
liver	UBERON:0002107	94.13	gold quality
male germ line stem cell (sensu Vertebrata) in testis	CL:0000089 ∩ UBERON:0000473	80.69	gold quality
endometrium epithelium	UBERON:0004811	70.42	gold quality
primordial germ cell in gonad	CL:0000670 ∩ UBERON:0000991	55.79	gold quality
buccal mucosa cell	CL:0002336	54.30	silver quality
oocyte	CL:0000023	53.14	gold quality
endothelial cell	CL:0000115	52.80	gold quality
cranial nerve II	UBERON:0000941	50.79	silver quality
frontal pole	UBERON:0002795	50.41	gold quality
middle frontal gyrus	UBERON:0002702	50.30	gold quality
paraflocculus	UBERON:0005351	50.18	gold quality
Brodmann (1909) area 10	UBERON:0013541	50.18	gold quality
quadriceps femoris	UBERON:0001377	49.96	gold quality
thymus	UBERON:0002370	49.70	gold quality
vastus lateralis	UBERON:0001379	49.51	gold quality
Brodmann (1909) area 46	UBERON:0006483	49.30	gold quality
blood vessel layer	UBERON:0004797	49.29	gold quality
cerebellar vermis	UBERON:0004720	49.25	gold quality
cervix squamous epithelium	UBERON:0006922	49.20	gold quality
hair follicle	UBERON:0002073	49.18	gold quality
olfactory bulb	UBERON:0002264	48.92	gold quality
choroid plexus epithelium	UBERON:0003911	48.89	gold quality
adult mammalian kidney	UBERON:0000082	48.87	gold quality
myocardium	UBERON:0002349	48.87	gold quality
type B pancreatic cell	CL:0000169	48.83	gold quality
oviduct epithelium	UBERON:0004804	48.82	gold quality
cardiac muscle of right atrium	UBERON:0003379	48.55	gold quality
CA1 field of hippocampus	UBERON:0003881	48.50	gold quality
nephron tubule	UBERON:0001231	48.37	silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	3.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

39 targeting SLC17A2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-5692A	100.00	74.40	6850
HSA-MIR-568	99.98	69.86	2084
HSA-MIR-23B-5P	99.98	66.07	587
HSA-MIR-12136	99.98	72.81	5713
HSA-MIR-548AJ-3P	99.96	73.38	5345
HSA-MIR-548X-3P	99.96	73.38	5345
HSA-MIR-1250-3P	99.96	70.04	4038
HSA-MIR-590-3P	99.96	74.34	6478
HSA-MIR-548J-3P	99.94	72.61	4881
HSA-MIR-23A-5P	99.94	65.39	468
HSA-MIR-548AE-3P	99.93	72.66	4867
HSA-MIR-548AH-3P	99.93	72.54	4872
HSA-MIR-548AM-3P	99.93	72.54	4872
HSA-MIR-548AQ-3P	99.93	72.66	4867
HSA-MIR-5582-3P	99.86	72.48	4221
HSA-MIR-4307	99.82	70.45	3374
HSA-MIR-4306	99.72	70.50	3630
HSA-MIR-33A-3P	99.70	70.27	3362
HSA-MIR-6733-3P	99.54	67.80	1281
HSA-MIR-942-5P	99.41	68.40	1977
HSA-MIR-185-5P	99.35	68.60	2497
HSA-MIR-4644	99.35	69.12	2514
HSA-MIR-3191-5P	99.24	66.52	1722
HSA-MIR-664A-3P	99.22	71.08	2696
HSA-MIR-8077	99.17	66.67	862
HSA-MIR-4758-3P	99.12	63.96	869
HSA-MIR-4711-3P	98.97	66.87	1020
HSA-MIR-374A-3P	98.87	67.82	1531
HSA-MIR-3145-3P	98.85	69.07	2031
HSA-MIR-5094	98.63	67.11	1062

Literature-anchored findings (GeneRIF, showing 2)

• Association was detected in premenopausal women of European descent between percent iron saturation and variants in the chromosome 6 region containing both HFE and SLC17A2 genes. (PMID:26852655)
• a novel gout-associated gene, SLC17A2, was identified (OR = 0.83, PFDR = 0.017).The common variant rs2071299 is an expression associated SNP and SLC17A2 mRNA expression is modified by different genotypes of this variant. the mRNA expression and protein levels of SLC17A2 between healthy individuals and hyperuricemia patients were significantly different (PMID:29497127)

Cross-species orthologs

56 orthologs

Organism	Symbol	Gene ID
danio_rerio	slc17a5	ENSDARG00000055190
danio_rerio	slc37a4b	ENSDARG00000077180
danio_rerio	si:ch1073-513e17.1	ENSDARG00000086739
danio_rerio	slc37a4bl	ENSDARG00000093531
mus_musculus	Slc17a2	ENSMUSG00000036110
rattus_norvegicus	Slc17a2	ENSRNOG00000017180
drosophila_melanogaster	dmGlut	FBGN0010497
drosophila_melanogaster	MFS14	FBGN0010651
drosophila_melanogaster	Picot	FBGN0024315
drosophila_melanogaster	CG9254	FBGN0028513
drosophila_melanogaster	CG6978	FBGN0029727
drosophila_melanogaster	VGlut	FBGN0031424
drosophila_melanogaster	CG7881	FBGN0033048
drosophila_melanogaster	MFS12	FBGN0033234
drosophila_melanogaster	MFS15	FBGN0034392
drosophila_melanogaster	CG15096	FBGN0034394
drosophila_melanogaster	MFS16	FBGN0034611
drosophila_melanogaster	CG12490	FBGN0034782
drosophila_melanogaster	CG9825	FBGN0034783
drosophila_melanogaster	CG9826	FBGN0034784
drosophila_melanogaster	CG3649	FBGN0034785
drosophila_melanogaster	CG2003	FBGN0039886
drosophila_melanogaster	CG30265	FBGN0050265
drosophila_melanogaster	MFS1	FBGN0050272
caenorhabditis_elegans		WBGENE00001135
caenorhabditis_elegans		WBGENE00007669
caenorhabditis_elegans		WBGENE00008000
caenorhabditis_elegans		WBGENE00008677
caenorhabditis_elegans		WBGENE00010755
caenorhabditis_elegans		WBGENE00010931
caenorhabditis_elegans		WBGENE00011185
caenorhabditis_elegans		WBGENE00011349
caenorhabditis_elegans		WBGENE00011556
caenorhabditis_elegans		WBGENE00011688
caenorhabditis_elegans		WBGENE00012443
caenorhabditis_elegans		WBGENE00015271
caenorhabditis_elegans		WBGENE00015272
caenorhabditis_elegans		WBGENE00016003
caenorhabditis_elegans		WBGENE00018429
caenorhabditis_elegans		WBGENE00018918
caenorhabditis_elegans		WBGENE00018920
caenorhabditis_elegans		WBGENE00019187
caenorhabditis_elegans		WBGENE00019655
caenorhabditis_elegans		WBGENE00020583
caenorhabditis_elegans		WBGENE00020584
caenorhabditis_elegans		WBGENE00020697
caenorhabditis_elegans		WBGENE00020698
caenorhabditis_elegans		WBGENE00020699
caenorhabditis_elegans		WBGENE00020700
caenorhabditis_elegans		WBGENE00021157
caenorhabditis_elegans		WBGENE00021158
caenorhabditis_elegans		WBGENE00021219
caenorhabditis_elegans		WBGENE00021220
caenorhabditis_elegans		WBGENE00021223
caenorhabditis_elegans		WBGENE00021226
caenorhabditis_elegans		WBGENE00302978

Paralogs (12): SLC17A6 (ENSG00000091664), SLC17A9 (ENSG00000101194), SLC17A7 (ENSG00000104888), SLC17A5 (ENSG00000119899), SLC17A3 (ENSG00000124564), SLC17A1 (ENSG00000124568), SLC37A2 (ENSG00000134955), SLC37A4 (ENSG00000137700), SLC17A4 (ENSG00000146039), SLC37A3 (ENSG00000157800), SLC37A1 (ENSG00000160190), SLC17A8 (ENSG00000179520)

Protein

Protein identifiers

Sodium-dependent phosphate transport protein 3 — O00624 (reviewed: O00624)

Alternative names: Na(+)/PI cotransporter 3, Sodium/phosphate cotransporter 3, Solute carrier family 17 member 2

All UniProt accessions (1): O00624

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a membrane potential-dependent organic anion transporter, the transport requires a low concentration of chloride ions. Mediates chloride-dependent transport of urate. Can actively transport inorganic phosphate into cells via Na(+) cotransport.

Subcellular location. Apical cell membrane.

Tissue specificity. Expressed in the small intestine, kidney, spleen and testis. Not detected in fetal brain, bone marrow, and mammary gland.

Similarity. Belongs to the major facilitator superfamily. Sodium/anion cotransporter family.

Isoforms (3)

UniProt ID	Names	Canonical?
O00624-1	1	yes
O00624-2	2
O00624-3	3

RefSeq proteins (3): NP_001273052, NP_001273054, NP_005826 (=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR011701	MFS	Family
IPR020846	MFS_dom	Domain
IPR036259	MFS_trans_sf	Homologous_superfamily
IPR050382	MFS_Na/Anion_cotransporter	Family

Pfam: PF07690

Catalyzed reactions (Rhea), 2 shown:

• 3 Na(+)(out) + phosphate(out) = 3 Na(+)(in) + phosphate(in) (RHEA:71255)
• urate(out) + n chloride(in) = urate(in) + n chloride(out) (RHEA:72319)

UniProt features (16 total): transmembrane region 9, glycosylation site 4, splice variant 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-O00624-F1	83.34	0.50

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (4): 47, 56, 68, 69

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 97 (showing top): MODULE_162, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, TCF4_Q5, MODULE_368, RGTTAMWNATT_HNF1_01, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, GOBP_ORGANIC_ANION_TRANSPORT, GOCC_APICAL_PLASMA_MEMBRANE, GCM_TEC, HNF1_C, USF_02, LEF1_Q6, GCM_CDH5, GOBP_TRANSMEMBRANE_TRANSPORT

GO Biological Process (7): phosphate-containing compound metabolic process (GO:0006796), sodium ion transport (GO:0006814), monoatomic ion transport (GO:0006811), inorganic anion transport (GO:0015698), urate transport (GO:0015747), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085)

GO Molecular Function (4): sodium:phosphate symporter activity (GO:0005436), urate transmembrane transporter activity (GO:0015143), transmembrane transporter activity (GO:0022857), symporter activity (GO:0015293)

GO Cellular Component (3): plasma membrane (GO:0005886), membrane (GO:0016020), apical plasma membrane (GO:0016324)

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
transport	3
metabolic process	1
metal ion transport	1
nitrogen compound transport	1
sodium ion transport	1
monoatomic cation transmembrane transport	1
cellular process	1
phosphate transmembrane transporter activity	1
solute:sodium symporter activity	1
urate transport	1
salt transmembrane transporter activity	1
transporter activity	1
transmembrane transport	1
secondary active transmembrane transporter activity	1
membrane	1
cell periphery	1
cellular anatomical structure	1
apical part of cell	1
plasma membrane region	1

Protein interactions and networks

STRING

604 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
SLC17A2	SLC34A1	Q06495	742
SLC17A2	SLC20A1	Q8WUM9	637
SLC17A2	SLC20A2	Q08357	585
SLC17A2	HFE	Q30201	544
SLC17A2	SLC34A3	Q8N130	430
SLC17A2	SLC18B1	Q6NT16	389
SLC17A2	SLC2A9	Q9NRM0	335
SLC17A2	ITPK1	Q13572	327
SLC17A2	KRT38	O76015	320
SLC17A2	LGI4	Q8N135	307
SLC17A2	SASH1	O94885	296
SLC17A2	PPCDC	Q96CD2	290
SLC17A2	SLC22A11	Q9NSA0	288
SLC17A2	SLC18A3	Q16572	282
SLC17A2	SLC22A9	Q8IVM8	271

IntAct

2 interactions, top by confidence:

A	B	Type	Score
SLC17A2	ABCD4	psi-mi:“MI:0914”(association)	0.350

BioGRID (94): LRRC8D (Affinity Capture-MS), KCNT2 (Affinity Capture-MS), UBB (Affinity Capture-MS), ABCD4 (Affinity Capture-MS), ANO10 (Affinity Capture-MS), ABCB9 (Affinity Capture-MS), TAP2 (Affinity Capture-MS), SARAF (Affinity Capture-MS), ABCC10 (Affinity Capture-MS), SLC16A13 (Affinity Capture-MS), ATP8A1 (Affinity Capture-MS), SLC12A6 (Affinity Capture-MS), KIAA0195 (Affinity Capture-MS), KCNJ11 (Affinity Capture-MS), RHBDD3 (Affinity Capture-MS)

ESM2 similar proteins: A4FV52, A6QLI1, O00476, O00624, O61369, O62786, P34272, P34644, P38142, Q03567, Q05B21, Q10046, Q14916, Q1L8X9, Q21455, Q28722, Q2QWW7, Q32LF0, Q3TXX4, Q3UHK1, Q5NCM1, Q5SZA1, Q5W8I7, Q5W8I8, Q61983, Q62634, Q62795, Q66KG0, Q6INC8, Q7TSF2, Q7ZX53, Q8BFU8, Q8BLE7, Q8NDX2, Q921A2, Q95R48, Q961J5, Q96QE2, Q9C757, Q9FKV1

Diamond homologs: A4FV52, A6QLI1, O00476, O00624, O61369, O82390, P34644, Q03567, Q05B21, Q0IZQ3, Q10046, Q14916, Q1L8X9, Q28722, Q2QWW7, Q32LF0, Q3E9A0, Q3TXX4, Q53P54, Q5NCM1, Q5Q0U0, Q5SZA1, Q5W8I7, Q5W8I8, Q61983, Q62634, Q62795, Q652N5, Q66GI9, Q6INC8, Q7TSF2, Q8BFU8, Q8BLE7, Q8BN82, Q8GX78, Q8NDX2, Q9FKV1, Q9JI12, Q9MZD1, Q9NRA2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

66 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	58
Likely benign	3
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1328 predictions. Top by Δscore:

Variant	Effect	Δscore
6:25918482:CTCA:C	donor_loss	1.0000
6:25918483:TCA:T	donor_loss	1.0000
6:25918484:CACCA:C	donor_loss	1.0000
6:25918485:A:AC	donor_gain	1.0000
6:25918486:C:CC	donor_gain	1.0000
6:25918570:GACCC:G	acceptor_gain	1.0000
6:25918571:ACCC:A	acceptor_loss	1.0000
6:25918571:ACCCT:A	acceptor_gain	1.0000
6:25918572:CC:C	acceptor_gain	1.0000
6:25918573:CC:C	acceptor_gain	1.0000
6:25918574:C:A	acceptor_loss	1.0000
6:25918574:C:CC	acceptor_gain	1.0000
6:25918575:T:A	acceptor_loss	1.0000
6:25921092:CC:C	acceptor_gain	1.0000
6:25921093:CC:C	acceptor_gain	1.0000
6:25923692:TAC:T	donor_loss	1.0000
6:25923693:A:AC	donor_gain	1.0000
6:25923693:AC:A	donor_gain	1.0000
6:25923693:ACCTT:A	donor_loss	1.0000
6:25923694:C:CG	donor_gain	1.0000
6:25923694:CC:C	donor_gain	1.0000
6:25923694:CCT:C	donor_gain	1.0000
6:25923694:CCTT:C	donor_gain	1.0000
6:25923694:CCTTT:C	donor_gain	1.0000
6:25923905:ACC:A	acceptor_loss	1.0000
6:25923907:C:CC	acceptor_gain	1.0000
6:25913449:ATCCT:A	acceptor_loss	0.9900
6:25913450:TCC:T	acceptor_loss	0.9900
6:25913451:CCT:C	acceptor_loss	0.9900
6:25913452:CTA:C	acceptor_loss	0.9900

AlphaMissense

3107 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
6:25921054:A:G	W172R	0.996
6:25921054:A:T	W172R	0.996
6:25921052:C:A	W172C	0.994
6:25921052:C:G	W172C	0.994
6:25915532:C:T	G393E	0.991
6:25915533:C:A	G393W	0.990
6:25915736:C:G	G355R	0.987
6:25915736:C:T	G355R	0.987
6:25921063:A:G	W169R	0.987
6:25921063:A:T	W169R	0.987
6:25915519:G:C	N397K	0.986
6:25915519:G:T	N397K	0.986
6:25915756:C:G	R348P	0.986
6:25916763:G:C	S284R	0.984
6:25916763:G:T	S284R	0.984
6:25916765:T:G	S284R	0.984
6:25917058:A:G	W227R	0.984
6:25917058:A:T	W227R	0.984
6:25921395:C:A	W86C	0.984
6:25921395:C:G	W86C	0.984
6:25921397:A:G	W86R	0.984
6:25921397:A:T	W86R	0.984
6:25915533:C:G	G393R	0.983
6:25915533:C:T	G393R	0.983
6:25918497:G:C	F213L	0.983
6:25918497:G:T	F213L	0.983
6:25918499:A:G	F213L	0.983
6:25921031:G:C	S179R	0.983
6:25921031:G:T	S179R	0.983
6:25921033:T:G	S179R	0.983

dbSNP variants (sampled 300 via entrez): RS1000080460 (6:25913069 G>A,T), RS1000144806 (6:25930520 A>G), RS1000327892 (6:25925861 T>C), RS1000443996 (6:25926247 G>A), RS1000603671 (6:25932495 A>T), RS1000946174 (6:25922444 A>G), RS1000996792 (6:25922123 G>A,C), RS1001121629 (6:25928712 T>G), RS1001437905 (6:25927750 G>A), RS1001574218 (6:25920886 A>G), RS1001794292 (6:25931975 G>A), RS1001968200 (6:25916103 C>A,T), RS1002082816 (6:25916332 C>T), RS1002223713 (6:25932277 G>A), RS1002973031 (6:25917958 G>C)

Disease associations

OMIM: gene MIM:611049 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL3769300 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Type I sodium-phosphate co-transporters

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Benzo(a)pyrene	affects methylation, decreases expression	4
Cyclosporine	affects expression, increases expression	4
Aflatoxin B1	affects expression, decreases expression, increases methylation	4
Acetaminophen	decreases expression	2
Tetrachlorodibenzodioxin	decreases expression	2
OTX015	decreases expression	1
mivebresib	decreases expression	1
uranyl acetate	affects expression	1
bisphenol A	affects cotreatment, increases methylation, decreases methylation	1
kojic acid	decreases expression	1
3,4,3’,4’-tetrachlorobiphenyl	affects expression	1
resorcinol	decreases expression	1
CGP 52608	affects binding, increases reaction	1
(+)-JQ1 compound	decreases expression	1
Resveratrol	affects cotreatment, decreases expression	1
Fulvestrant	affects cotreatment, increases methylation	1
Estradiol	decreases expression	1
Hydrogen Peroxide	affects expression	1
Plant Extracts	affects cotreatment, decreases expression	1
Quercetin	decreases expression	1
Smoke	increases expression	1
Uranium	affects expression	1
Urethane	decreases expression	1
Valproic Acid	decreases expression, decreases methylation	1
2,4-Dichlorophenoxyacetic Acid	decreases expression	1
Zidovudine	decreases expression	1
Copper Sulfate	increases expression	1
tert-Butylhydroperoxide	affects expression	1
Vitamin K 3	affects expression	1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay ID	Type	Description	Source paper
CHEMBL3773489	Binding	Inhibition of NaPiA3 (unknown origin)	Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family. — J Med Chem

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_D4RY	HuH7-SLC17A2-KO-c2	Cancer cell line	Male
CVCL_D4RZ	HuH7-SLC17A2-KO-c3	Cancer cell line	Male

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.